The FDA requirement for the tox study to be completed will dlow down any collaboration. That trial is underway, but would need to be completed and presented to FDA to extend any 6 month human dose there. So end of yearish ?
I would have thought they would have been sniffing around already if they were interested. And still risk until that tox study is done and dusted.
ANP Price at posting:
6.5¢ Sentiment: Buy Disclosure: Held
